NT-proBNP in Stable COPD and Future Exacerbation Risk: Analysis of the SPIROMICS Cohort

BACKGROUND: High N-terminal pro-brain natriuretic peptide (NT-proBNP) during COPD exacerbations is associated with worse clinical outcomes. The prognostic value of NT-proBNP measured during clinical stability has not been well characterized. METHODS: We studied SPIROMICS participants 40–80 years of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Respir Med
Autori principali: Labaki, Wassim W., Xia, Meng, Murray, Susan, Curtis, Jeffrey L., Barr, R. Graham, Bhatt, Surya P., Bleecker, Eugene R., Hansel, Nadia N., Cooper, Christopher B., Dransfield, Mark T., Wells, J. Michael, Hoffman, Eric A., Kanner, Richard E., Paine, Robert, Ortega, Victor E., Peters, Stephen P., Krishnan, Jerry A., Bowler, Russell P., Couper, David J., Woodruff, Prescott G., Martinez, Fernando J., Martinez, Carlos H., Han, MeiLan K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6084793/
https://ncbi.nlm.nih.gov/pubmed/29957287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmed.2018.06.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi